Tinnitus Clinical Trials: How to Understand Emerging Research

The short answer

A registered clinical trial means a treatment is being tested, not that it works. Most tinnitus drug candidates that reached Phase 2 or 3 have failed, and company press releases routinely sound stronger than the eventual published data. The tools below help you read trial news without being misled.

Five things to check in any tinnitus trial

• The primary endpoint — was it met? A trial that failed its primary endpoint but reports a positive subgroup is a negative trial with a lead for future research.
• Loudness or distress? THI/TFI questionnaires measure impact, not volume.
• The control group — tinnitus improves substantially on placebo/waitlist; uncontrolled improvement proves little. In one gabapentin trial both arms improved ~11 points equally.
• Who ran it — sponsor-run results await independent replication.
• Published or press-released? Toplines can precede (or replace) peer-reviewed data by years — some failed programs never published their results at all.

Trials we track now

All 21 tracked trials with statuses verified weekly against ClinicalTrials.gov. Only a study's research team can determine whether anyone is eligible.